Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of ...

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 ...

Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

So Sir Pascal may seem an unlikely ally of Donald Trump, who as America’s president has slashed public spending on scientific ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was “rapidly ...

AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation that it will ditch ...

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

It plans to invest $50 billion in the US over five years, including building its largest-ever manufacturing facility in ...

Some home truths for London: One, it makes sense for AstraZeneca Plc to move its main listing to New York, and two, such a terrible symbolic blow for the UK would be hard to stop. The goal — if ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...